Suppr超能文献

活体供肝肝移植(LDLT)是亚洲的发展方向。

Living donor liver transplant (LDLT) is the way forward in Asia.

机构信息

Institute of Liver Disease and Transplantation, Global Health City, Chennai, India.

National Foundation for Liver Research, Chennai, India.

出版信息

Hepatol Int. 2017 Mar;11(2):148-151. doi: 10.1007/s12072-016-9780-z. Epub 2017 Jan 17.

Abstract

Living donor liver transplantation (LDLT) is currently the commonest form of liver transplantation in Asia. Efforts to improve the number of deceased donor liver transplantation have not been uniformly successful. We believe that THE unique combination of demographic, social, economic and political factors that exist in Asia will ensure that LDLT will continue to remain the predominant form of liver transplantation. While efforts to increase deceased donation rates should continue and intensify, progress in LDLT should also be supported and encouraged, as it will be the main workhorse of liver transplantation in Asia in the near and medium-term future.

摘要

活体肝移植(LDLT)目前是亚洲最常见的肝移植形式。增加已故供体肝移植数量的努力并非都取得了成功。我们认为,亚洲独特的人口、社会、经济和政治因素的综合作用将确保 LDLT 将继续成为肝移植的主要形式。虽然应该继续并加强增加已故供体捐献率的努力,但也应该支持和鼓励 LDLT 的进展,因为它将是亚洲在近期和中期内肝移植的主要动力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验